___

• Senior R, Dwivedi G, Hayat S, Lim TK. Clinical benefit of contrast-enhanced echocardiography during rest and stress examinations. Eur J Echocardiogr 2005;6 Suppl 2: 6–13.
• Firschke, C, Koberl, B, von Bibra, H. Combined use of con- trast-enhanced 2-dimensional and color Doppler echocardi- ography for improved left ventricular endocardial border deli- neation using levovist, a new venous echocardiographic con- trast agent. Int J Card Imaging 1997; 13: 137–44.
• Mulvagh SL, DeMaria AN, Feinstein SB. Contrast echocar- diography: current and future applications. Am Soc Echocar- diogr. 2000; 13(4) :331–42.
• Lenci I, Alvior A, Manzia TM, Toti L, Neuberger J, Steeds R. Saline contrast echocardiography in patients with hepatopul- monary syndrome awaiting liver transplantation.J Am Soc Ec- hocardiogr. 2009; 22(1): 89–94.
• Kurflaklıoğlu H, İyisoy A. Platipne-ortodeoksi sendromu ve kateter yoluyla tedavisi. Türk Kardiyol Dern Arfl 2005; 33: 304–8. 66.. Weissman NJ, Cohen MC, Hack TC. Infusion versus bolus contrast echocardiography: A multicenter, open-label, cros- sover trial. Am Heart J 2000; 139:399–404.
• Kaul S. Myocardial contrast echocardiography: 15 years of research and development. Circulation 1997; 96: 3745–60.
• Mulvagh SL, Rakowski H, Vannan MA. American Society of Echocardiography. American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultraso- nic Contrast Agents in Echocardiography.J Am Soc Echocar- diogr. 2008; 21(11):1179–201.
• Douglas PS, Weyman AE, Lindner JR, Wei K. Contrast ec- hocardiography: Past, present and . . . Future? J Am Coll Car- diol Img 2008; 1: 107–10.
• Colon PJ 3rd, Richards DR, Moreno CA, et al. Benefits of reducing the cardiac cycle-triggering frequency of ultrasound imaging to increase myocardial opacification with fso69 du- ring fundamental and second harmonic imaging. J Am Soc Echocardiogr 1997; 10: 602–7.
• Firschke C, Lindner JR, Wei K. Myocardial perfusion ima- ging in the setting of coronary artery stenosis and acute myo- cardial infarction using venous injection of a second-genera- tion echocardiographic contrast agent. Circulation 1997; 96: 959–67.
• Porter TR, Kricsfeld A, Deligonul U, Xie F. Detection of re- gional perfusion abnormalities during adenosine stress echo- cardiography with intravenous perfluorocarbon-exposed so- nicated dextrose albumin. Am Heart J 1996; 132: 41–7.
• Hundley WG, Kizilbash AM, Franco F. Administration of an intravenous pefluorocarbon contrast agent improves echo- cardiographic determination of left ventricular volumes and ejection fraction: Comparison with cine magnetic resonance imaging. J Am Coll Cardiol 1998; 31: 1426–32 .
• Chow CM, Lim KD, Wu L, Leong-Poi H. Images in cardi- ovascular medicine: isolated left ventricular noncmpaction enhanced by echocontrast agent. Circulation 2007;116: 90–1. 1155.. Nagueh SF, Lakkis NM, He Z-X. Role of myocardial con- trast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 1998; 32: 225–9.
• Jeetley P, Hickman M, Kamp O. Myocardial contrast echo- cardiography for the detection of coronary artery stenosis: a prospective multicenter study in comparison with single-pho- ton emission computed tomography. J Am Coll Cardiol 2006; 47:141-5.
• Kaul S, Senior R, Firschke Cl. Incremental value of cardiac imaging in patients presenting to the emergency department with chest pain and without ST-segment elevation: A multicen- ter study. American Heart Journal, 2004;148: 129–36.
• Eeckhout E. and Kern MJ. The coronary no-reflow pheno- menon: a review of mechanisms and therapies. European He- art Journal 2001: 22, 729–39.
• Main M, Magalski A, Morris B. Combined assessment of microvascular integrity and contractile reserve improves diffe- rentiation of stunning and necrosis after acute anterior wall myocardial infarction. Journal of the American College of Car- diology, 2002;40: 1079–84.
• Hayat SA, Senior R. Myocardial contrast echocardiog- raphy in ST elevation myocardial infarction: ready for prime ti- me? European Heart Journal 2008;29: 299–314.
• Vernon SM, Camarano, G, Kaul, S. Myocardial contrast ec- hocardiography demonstrates that collateral flow can preser- ve myocardial function beyond a chronically occluded coro- nary artery. Am J Cardiol 1996; 78: 958–60.
• Shimoni S, Frangogiannis NG, Aggeli CJ. Identification of hibernating myocardium with quantitative intravenous myo- cardial contrast echocardiography: comparison with dobuta- mine echocardiography and thallium-201 scintigraphy. Circu- lation 2003; 107: 538–44.
• Youn HJ, Foster E. Demonstration of coronary artery flow using transthrasic Doppler echocardiography .Journal of American Society of Echocardiography.2004;17:178-85.
• Kaufmann BA, Sanders JM, Davis C, Xie A, Aldred P, Sa- rembock IJ, et al. Lindner JR. Molecular imaging of inflamma- tion in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. Circulation. 2007;116(3): 276–84.
• Voigt JU. Ultrasound molecular imaging. Methods. 2009;48(2): 92–7.
• Kofluyolu Heart Journal